Our UK Manufacturing
Sterile injectable products manufactured to GMP* Guidelines
Products made in the UK
Our comprehensive UK manufacturing plant in Wrexham is responsible for the manufacture of our sterile injectable products. Our facility is approved by the MHRA** and FDA,*** with a recent successful inspection by the FDA in August 2013. Additionally, our facility is also audited and approved by other highly accredited Global regulatory bodies. The UK manufacturing site operates as C.P. Pharmaceuticals, a subsidiary of Wockhardt UK Limited.
A wide range of injectable products
Originally established in 1950 as Weddel, Wockhardt UK has several decades of experience in manufacturing a wide spectrum of sterile injectable products and is also a leading contract manufacturer for our customers in both the UK and Global markets.
Our sterile injectable products cover a wide range of therapy areas including insulin for diabetes, heparin for anticoagulation and also pain management. Our products are available in the most widely used presentations, including cartridges, vials and ampoules and in either liquid or lyophilised forms (dry powder), in a range of sizes.
Our UK facility has three production lines that were set to produce approximately 14 million units during 2013. The plant’s fully-automated vision inspection equipment checks approximately 24,000 units per hour. This means we can check and supply our products to our customers quickly and without compromising on quality.
An expansion to the facility is planned during the third quarter of 2014. A high-speed combination line for vials and ampoules will be installed, which looks set to double the output of the facility.
*Good Manufacturing Practice is that part of quality assurance which ensures that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorisation (MA) or product specification. GMP is concerned with both production and quality control
**Medicines and Healthcare Products Regulatory Agency
***Food and Drug Administration